@article {1065,
	title = {HTLV-I-associated myelopathy manifested after renal transplantation},
	journal = {J Neurol Sci},
	volume = {177},
	year = {2000},
	note = {Nakatsuji, Y Sugai, F Watanabe, S Kaido, M Koguchi, K Abe, K Sakoda, S Case Reports Netherlands Journal of the neurological sciences J Neurol Sci. 2000 Aug 15;177(2):154-6.},
	month = {Aug 15},
	pages = {154 - 6},
	edition = {36781},
	abstract = {We report a patient with HTLV-I-associated myelopathy (HAM), who developed symptoms of myelopathy 4 years after cadaveric renal transplantation. Since he was seronegative before the transplantation, it is suggested that HTLV-I infection was transmitted via renal graft transplantation. He has been treated with immunosuppressive agents such as cyclosporin A (CsA), mycophenolate mofetil (MMF), and prednisolone (PSL) to prevent graft rejection. This case suggested that these immunosuppressive agents are poorly effective in suppressing either the onset or progression of HAM/TSP.},
	keywords = {Humans, Immunosuppressive Agents / adverse effects, Kidney Failure, Chronic / surgery, Kidney Transplantation / *adverse effects, Male, Middle Aged, Paraparesis, Tropical Spastic / *pathology / transmission},
	issn = {0022-510X (Print) 0022-510X (Linking)},
	doi = {S0022-510X(00)00332-4 [pii]},
	author = {Nakatsuji,Y. and Sugai,F. and Watanabe,S. and Kaido,M. and Koguchi,K. and Abe,K. and Sakoda,S.}
}
